IP Library Granted Patent US 7,467,011
Granted Patent B2
US 7,467,011 · App. 11/424,001 · Granted Dec 16, 2008

Hat for treating a tumor or the like

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,467,011
App. No.
11/424,001
Granted
Dec 16, 2008
Kind
B2
Abstract

An article of clothing is pro-vided for selectively destroying dividing cells in living tissue formed of dividing cells and non-dividing cells. The dividing cells contain polarizable intracellular members and during late anaphase or telophase, the dividing cells are connected to one another by a cleavage furrow. The article of clothing includes insulated electrodes to be coupled to a generator for subjecting the living tissue to electric field conditions sufficient to cause movement of the polarizable intracellular members toward the cleavage furrow in response to a non-homogeneous electric field being induced in the dividing cells. The non-homogeneous electric field produces an increased density electric field in the region of the cleavage furrow. The movement of the polarizable intracellular intracellular members towards the cleavage furrow causes the breakdown thereof which adversely impacts the multiplication of the dividing cells.

Claims (16)

1. A hat for treatment of an intra-cranial tumor or lesion by selectively destroying dividing cells of the tumor, the dividing cells having polarizable or polar or charged intracellular members, the hat comprising: a hat body to be worn over a head and including a predetermined number of openings formed therein; at least one insulated electrode unit for placement in one of the openings of the hat, each unit being a member having an insulated electrode disposed at one face thereof and a biasing mechanism for applying a biasing force against the insulated electrode in a direction away from the hat body, the insulated electrode being disposed at one face of the hat body when the unit is inserted and securely held within the opening; and an electric field source for applying an alternating electric potential across at least two insulated electrodes to create an electric field in the dividing cells, wherein passage of the electric field through the dividing cells in late anaphase or telophase transforms the electric field into a non-homogenous electric field that produces an increased density electric field in a region of a cleavage furrow of the dividing cells, wherein the non-homogeneous electric field produced within the dividing cells has amplitude and frequency characteristics such that long-term application of the electric field causes the destruction of cells as they divide, but wherein the electric field is sufficiently small so that during long-term application of the electric field, the destruction of the dividing cells is not caused by heat.

2. The hat of claim 1 , wherein the unit includes a first electric connector for attachment to a conductor which is coupled at its opposite end to the electric field source.

3. The hat of claim 1 , wherein the unit is securely retained within the opening by an adhesive member that has an adhesive layer formed on at least one side thereof, the adhesive member being disposed around a peripheral edge of the insulated electrode and over a peripheral edge of the hat body around the opening for securely positioning and retaining the unit within the opening with the insulated electrode being positioned at one face of the hat body.

4. The hat of claim 1 , wherein the alternating electric potential has a frequency of between about 50 KHz to about 500 KHz.

5. The hat of claim 1 , wherein the electric field source comprises a generator that generates an alternating voltage waveform at frequencies between about 50 KHz to about 500 KHz that activate each insulated electrode.

6. The hat of claim 5 , wherein the generator is disposed within the hat body.

7. The hat of claim 1 , wherein the biasing mechanism includes a spring that applies a biasing force against one of the first and second electrodes in the direction toward the living tissue.

8. The hat of claim 7 , wherein the biasing mechanism is contained within a unit that is detachably coupled to the hat to permit removal and replacement thereof.

9. The hat of claim 1 , wherein the biasing mechanism comprises a body formed of an elastic material that is disposed within the article of clothing in close proximity to or in contact with one of the insulated electrodes.

10. The hat of claim 1 , wherein each insulated electrode includes a conductor and a dielectric member in contact therewith and for placement against the head to form a capacitor.

11. The hat of claim 10 , wherein the insulated electrode includes an intervening filler disposed on the respective dielectric member thereof, the intervening filler being formed of a material that has high conductance and a high dielectric constant.

12. The hat of claim 11 , wherein the intervening filler comprises a gel formed of at least one material selected from the group consisting of gelatins and agar.

13. The hat of claim 1 , wherein the at least one insulated electrode unit is removably disposed within one of the openings of the hat.

14. The hat of claim 1 , wherein the insulated electrode is free from a planar shape and is shaped to have a contour complementary to a skin surface of the head.

15. The hat of claim 1 , wherein the alternating electric potential has a frequency of between about 100 KHz to about 300 KHz.

16. The hat of claim 1 , wherein the electric field source comprises a generator that generates an alternating voltage waveform at frequencies between about 100 KHz to about 300 KHz that activate each insulated electrode.

Assignments (18)
PATENT SECURITY AGREEMENT Recorded May 4, 2024
From: NOVOCURE GMBH (SWITZERLAND)
To: BIOPHARMA CREDIT PLC
Reel/Frame 067315/0399 →
RELEASE OF SECURITY INTEREST Recorded Apr 24, 2024
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: NOVOCURE GMBH
Reel/Frame 067211/0839 →
SECURITY INTEREST Recorded Nov 6, 2020
From: NOVOCURE GMBH
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 054344/0510 →
RELEASE OF SECURITY INTEREST FOR PATENT SECURITY AGREEMENT FILED AT REEL/FRAME 45278 0825 Recorded Aug 25, 2020
From: BIOPHARMA CREDIT PLC
To: NOVOCURE LIMITED
Reel/Frame 053597/0335 →
RELEASE OF SECURITY INTEREST FOR PATENT SECURITY AGREEMENT FILED AT REEL/FRAME 50395/0398 Recorded Aug 19, 2020
From: BPCR LIMITED PARTNERSHIP
To: NOVOCURE GMBH
Reel/Frame 053538/0623 →
OMNIBUS CONFIRMATION OF ASSIGNMENT AGREEMENT Recorded May 21, 2020
From: BIOPHARMA CREDIT PLC
To: BPCR LIMITED PARTNERSHIP
Reel/Frame 052741/0173 →
RELEASE OF SECURITY INTEREST FOR PATENT SECURITY AGREEMENT FILED AT REEL/FRAME 045278/0825 Recorded Apr 14, 2020
From: BIOPHARMA CREDIT PLC
To: NOVOCURE LIMITED
Reel/Frame 052391/0549 →
RELEASE OF SECURITY INTEREST Recorded Apr 13, 2020
From: BIOPHARMA CREDIT PLC
To: NOVOCURE LIMITED
Reel/Frame 052383/0705 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 20, 2019
From: NOVOCURE LIMITED
To: NOVOCURE GMBH
Reel/Frame 050110/0098 →
SECURITY INTEREST Recorded May 6, 2019
From: NOVOCURE GMBH
To: BIOPHARMA CREDIT PLC
Reel/Frame 050395/0398 →
SECURITY INTEREST Recorded Feb 7, 2018
From: NOVOCURE LIMITED
To: BIOPHARMA CREDIT PLC
Reel/Frame 045284/0851 →
RELEASE OF SECURITY INTEREST Recorded Feb 7, 2018
From: BIOPHARMA SECURED INVESTMENTS III HOLDINGS CAYMAN LP
To: NOVOCURE LIMITED
Reel/Frame 044858/0416 →
SECURITY INTEREST Recorded Feb 7, 2018
From: NOVOCURE LIMITED
To: BIOPHARMA CREDIT PLC
Reel/Frame 045278/0825 →
SECURITY INTEREST Recorded Feb 2, 2015
From: NOVOCURE LIMITED
To: BIOPHARMA SECURED INVESTMENTS III HOLDINGS CAYMAN LP
Reel/Frame 034866/0402 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 18, 2014
From: PALTI, YORAM
To: STANDEN LTD.
Reel/Frame 034548/0231 →
RELEASE OF SECURITY INTEREST Recorded Dec 20, 2013
From: DEUTSCHE BANK TRUST COMPANY AMERICAS
To: NOVOCURE LIMITED
Reel/Frame 031866/0567 →
SECURITY AGREEMENT Recorded Feb 20, 2013
From: NOVOCURE LIMITED
To: DEUTSCHE BANK TRUST COMPANY AMERICAS
Reel/Frame 029845/0135 →
CHANGE OF NAME Recorded May 19, 2011
From: STANDEN LIMITED
To: NOVOCURE LIMITED
Reel/Frame 026311/0210 →